Paper - WANFANG MED ONLINE

You Position: Home > Paper

Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary thromboembolism

( views:154, downloads:4 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 1

DOI:: No doi available

Key Word:: pulmonary thromboembolism;right ventricular dysfunction;cardiac troponin I;risk stratification;transthoracic echocardiography

Abstract： Background Acute pulmonary thromboembolism (APE) causes right ventricular dysfunction (RVD) and cardiac troponin I (cTnI) elevation. Patients with RVD and cTnl elevation have a worse prognosis. Thus, early detection of RVD and cTnl elevation is beneficial for risk stratification. In this study, we assessed 14-day adverse clinical events and combined RVD on transthoracic echocardiography (TTE) with cTnl in risk stratification among a broad spectrum of APE patients.Methods The prospective multi-centre trial included 90 patients with confirmed APE from 12 collaborating hospitals.Acute RVD on TTE was diagnosed in the presence of at least 2 of the following: right ventricular dilatation (without hypertrophy), loss of inspiratory collapse of inferior vena cava (IVC), right ventricular (RV) hypokinesis, tricuspid regurgitant jet velocity ＞2.8 m/s. The study patients were divided into two groups according to clinical and echocardiographic findings at presentation: Group Ⅰ: 50 patients with RVD; Group Ⅱ: 40 patients without RVD.Results More than half of the patients (50/90, 55.6%) had RVD. Nearly one third (26/90, 28.9%) of patients had elevated cTnl at presentation and only 4.2% on the fourth day after initial therapy. A multiple Logistic regression model implied RVD, right and left ventricular end-diastolic diameter ratio (RVED/LVED), and cTnl independently predict an adverse 14-day clinical outcome (P＜0.01). Receiver operating characteristics (ROC) curves revealed that the cut-off values of RVED/LVED and cTnl yielding the highest discriminating power were 0.65 and 0.11 ng/ml, respectively.Furthermore, the incidence of an adverse 14-day clinical event in patients with RVD and elevated cTnl was greater (40.7%) than in patients with elevated cTnl or positive RVD alone (0% and 8.3%, respectively) (P＜0.001).Conclusions RVD, RVED/LVED, and cTnl are independent predictors of 14-day clinical outcomes. The patients with RVED/LVED greater than 0.65 and cTnl higher than 0.11 ng/ml at presentation possibly have adverse 14-day events.RVD combined with cTnl can identify a subgroup of APE patients with a much more guarded prognosis.

Reference

[1]刘品明,Nicolas Meneveau,Francois Schiele,等.Predictors of long-term clinical outcome of patients with acute massive pulmonary embolism after thrombolytic therapy[J].2003,(4).
[2]Evangelos Giannitsis,Margit M&uuml,ller-Bardorff,etc.Independent Prognostic Value of Cardiac Troponin T in Patients With Confirmed Pulmonary Embolism[J].2000,102(2).
[3]Ary Ribeiro,Per Lindmarker,Anders Juhlin-Dannfelt,etc.Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate[J].1997,134(3).
[4]Stefano Grifoni,Iacopo Olivotto,Paolo Cecchini,etc.Short-Term Clinical Outcome of Patients With Acute Pulmonary Embolism, Normal Blood Pressure, and Echocardiographic Right Ventricular Dysfunction[J].2000,101(24).
[5]S, Konstantinides,A, Geibel,M, Olschewski,etc.Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry.[J].1997,96.
[6]Petterson TM,Silverstein MD,Lohse CM,etc.Incidence of venous thromboembolism in hospitalized patients vs community residents.[J].2001,76(11).
[7]Heusel G,Heinrich F,Konstantinides S,etc.Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.[J].2002,347(15).
[8]Nils Kucher,Samuel Goldhaber.Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism[J].2003,108(18).
[9]Kasper W.,Konstantinides S.,Geibel A.,etc.Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism.[J].1997.
[10]Horlander KT,Leeper KV.Troponin levels as a guide to treatment of pulmonary embolism.[J].2003,9(5).
[11]S Z, Goldhaber,L, Visani,M, De Rosa.Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)[J].1999,353(9162).
[12]Kenneth E, Wood.Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism.[J].2002,121(3).
[13]Gibson NS,Buller HR,Sohne M.Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism.[J].2005,11(5).
[14]Stavros Konstantinides,Annette Geibel,Manfred Olschewski,etc.Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism[J].2002,106(10).
[15]J E, Adams,G S, Bodor,V G, Dávila-Román,etc.Cardiac troponin I. A marker with high specificity for cardiac injury.[J].1993,88.
[16]John W, Kreit.The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism.[J].2004,125(4).